NASDAQ:RLAY

Relay Therapeutics Stock Forecast

etoro logo Buy RLAY
*Your capital is at risk
$19.94
+0.170 (+0.86%)
At Close: Aug 10, 2026

Should you buy RLAY stock?

Last updated:

Based on market data through , StockInvest.us rates Relay Therapeutics Inc. (RLAY) as a Buy Candidate with a technical score of 4.59 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Buy signal since
  • Price since signal Up 40.03%
  • 3-month trend forecast Up 54.36%
  • Buy Candidate 4.59
AI Analysis AI Analysis of RLAY AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RLAY to Watchlist?
Some Reasons Why To Add RLAY:
  • +513.5% price growth over the last year
  • +143.8% YTD performance
  • Low bankruptcy risk (Altman Z-Score: 24.45)
PDF

Green day on Monday for Relay Therapeutics Inc.
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 11, 2026 Gain 40.03%

The Relay Therapeutics Inc. stock price gained 0.86% on the last trading day (Monday, 10th Aug 2026), rising from $19.77 to $19.94. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 6.37% from a day low at $19.47 to a day high of $20.71. The price has risen in 7 of the last 10 days and is up by 6.97% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 355 thousand more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $53.24 million.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $19.01 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 54.36% during the next 3 months and, with a 90% probability hold a price between $29.35 and $36.60 at the end of this 3-month period.

RLAY Signals & Forecast

The Relay Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $19.47 and $19.03. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -3.90%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Relay Therapeutics Inc. stock

Relay Therapeutics Inc. finds support from accumulated volume at $19.74 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.24 between high and low, or 6.37%. For the last week, the stock has had daily average volatility of 5.10%.

Our recommended stop-loss: $19.14 (-4.02%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 22 days ago.)

Trading Expectations (RLAY) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Relay Therapeutics Inc. to open at $20.04, and during the day (based on 14 day Average True Range), to move between $19.40 and $20.48, which gives a possible trading interval of +/-$1.08 (+/-5.55%) up or down from last closing price. If Relay Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 5.55% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $20.01 (0.33%) than the support at $19.74 (1.00%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Relay Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Relay Therapeutics Inc. stock to perform well in the short-term.

Current score: 4.589 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $20.04 ( 0.502%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RLAY Performance

Trading levels for RLAY

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 21.28 6.72%
R2 20.81 4.34%
R1 20.51 2.88%
Price 19.94
S1 19.57 -1.87%
S2 19.27 -3.34%
S3 18.80 -5.72%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 20.75 4.06%
R1 20.01 0.326%
Price 19.94
S1 19.74 -1.00%
S2 18.56 -6.92%
S3 15.70 -21.26%

FAQ

What is the symbol for Relay Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Relay Therapeutics Inc. is RLAY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Relay Therapeutics Inc. Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Relay Therapeutics Inc. (RLAY) as a Buy Candidate with a technical score of 4.59 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Buy signal began on Jun 11, 2026, the price has risen 40.03%. The current 3-month trend forecast projects a rise of 54.36%.

How to buy Relay Therapeutics Inc. Stock?
Relay Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Relay Therapeutics Inc. Stock.

What's the current price of Relay Therapeutics Inc. Stock?
As of the end of day on the Aug 10, 2026, the price of an Relay Therapeutics Inc. (RLAY) share was $19.94.

What is the 52-week high and low for Relay Therapeutics Inc. Stock?
The 52-week high for Relay Therapeutics Inc. Stock is $20.79 and the 52-week low is $3.15.

What is the market capitalization of Relay Therapeutics Inc. Stock?
As of the Aug 10, 2026, the market capitalization of Relay Therapeutics Inc. is 3.49B.
Click to get the best stock tips daily for free!
ABOUT RELAY THERAPEUTICS INC.
Relay Therapeutics
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhibitor of fibroblast growth factor receptor 2 (FGFR2), which is in a first-in-human clinical trial for pa...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE